Researchers highlight how BSI infecting pathogens become more resilient

NewsGuard 100/100 Score

A recently published special issue of Virulence, "Bloodstream Infections", focuses on the resilience of bloodstream infections (BSI) and is endorsed by the European Study Group for Infections in Compromised Hosts of the European Society of Clinical Microbiology and Infectious Diseases. Guest Editor Dr. Claudio Viscoli, a Professor of Infectious Disease at the University of Genoa, outlines in an editorial "Bloodstream Infections: The Peak of the Iceberg" why a special issue was created focusing extensively on BSI.

Dr. Viscoli states, "BSI remain a formidable challenge for the infectious disease physician, but may become a mission impossible if we will not efficiently contrast the development of resistance." He highlights how the pattern of types of BSI infecting pathogens has been changing and growing more resilient, while also more concerning is the decreasing efficacy of many antibiotics. The articles contained within the BSI special issue further inform and illuminate these concerns. The BSI special issue contains a wide spectrum of clinical settings, with articles addressing patient populations of those at high risk of infections and also those who occasionally interrelate with BSI. Microbiological problems, especially antibiotic resistance, were also examined within the special issue.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers enhance CAR-T cells to target solid tumors